a Over the recent years, several Re(I) organometallic compounds have been shown to be toxic to various cancer cell lines. However, these compounds lacked sufficient selectivity towards cancer tissues to be used as novel chemotherapeutic agents. In this study, we probe the potential of two known N,N-bis(quinolinoyl) Re(I) tricarbonyl complex derivatives, namely Re(I) tricarbonyl [N,N-bis(quinolin-2-ylmethyl)-amino]-4-butane-1-amine (Re-NH 2 ) and Re(I) tricarbonyl [N,N-bis(quinolin-2-ylmethyl)amino]-5-valeric acid (Re-COOH), as photodynamic therapy (PDT) photosensitizers. Re-NH 2 and Re-COOH proved to be excellent singlet oxygen generators in a lipophilic environment with quantum yields of about 75%. Furthermore, we envisaged to improve the selectivity of Re-COOH via conjugation to two types of peptides, namely a nuclear localization signal (NLS) and a derivative of the neuropeptide bombesin, to form Re-NLS and Re-Bombesin, respectively. Fluorescent microscopy on cervical cancer cells (HeLa) showed that the conjugation of Re-COOH to NLS significantly enhanced the compound's accumulation into the cell nucleus and more specifically into its nucleoli. Importantly, in view of PDT applications, the cytotoxicity of the Re complexes and their bioconjugates increased significantly upon light irradiation. In particular, Re-Bombesin was found to be at least 20-fold more toxic after light irradiation. DNA photocleavage studies demonstrated that all compounds damaged DNA via singlet oxygen and, to a minor extent, superoxide production.
Introduction
Over the last few years, an impressive amount of organometallic compounds has been screened for cytotoxicity to various cancer cell lines. [1] [2] [3] [4] [5] [6] Among them, several organometallic rhenium complexes have been reported to possess an antiproliferative activity comparable to or even exceeding that of cisplatin. [7] [8] [9] [10] [11] [12] [13] However, to avoid the severe side-effects afflicting patients during chemotherapy, high cytotoxicity is not enough -an improved selectivity towards cancer cells is required. 14 One of the possible strategies to overcome this important problem is to identify a target specific to cancer cells -e.g. an overexpressed receptor -and to conjugate the active compound to a moiety recognized by that target. Rhenium compounds such as Re(I) tricarbonyl N,N-bis(quinolinoyl) complex derivatives can easily be coupled to potential targeting vectors, as previously reported by Valliant, Zubieta, Doyle, Metzler-Nolte and our group. [15] [16] [17] [18] [19] [20] [21] [22] [23] Due to their long lifetimes, polarized emission and large Stokes shifts, these organometallic complexes have been initially developed as luminescent probes [24] [25] [26] [27] [28] and proven themselves particularly useful to study the behaviour of bioconjugates in cells. As mentioned earlier, these probes have been coupled to numerous biologically relevant molecules, such as formyl peptide receptor targeting peptide, 15 biotin, 16 glucose, 17 β-breaker peptide derivatives, 18 folate, 19 cell permeation peptides, 20 vitamin B 12 , 21 and peptide nucleic acids. 22, 23 In addition to their imaging properties, some of the conjugates have shown therapeutic potential. For instance, the Re-β-breaker peptides inhibit amyloid plaque formation associated with Alzheimer's disease. 18 The Re-B 12 derivative showed only a moderate cytotoxicity to the choriocarcinoma cell line (BeWo), 21 but the Re-folate conjugate was found to be strongly toxic to human multidrug-resistant ovarian carcinoma (A2780/AD) and Chinese hamster ovary (CHO) cell lines. 19 Of note, the Re(I) complexes used in these studies also possess a certain anti-proliferative activity on their own. Importantly, due to the isostructurality of Re(I) with Tc(I), the 99m Tc bioconjugate analogues could be prepared in a few of these studies allowing radioimaging to be performed. 15, 16, 18, 29 Another approach to specifically kill cancer cells is to use an external trigger to select the area where an initially inactive compound can be activated. A good example of such an approach is photodynamic therapy (PDT 19, 21 Re-COOH was then successfully coupled to two different targeting peptides on the solid phase using a similar experiment described by Metzler-Nolte et al. 37, 38 to obtain the bioconjugates Re-NLS and Re-Bombesin, respectively (Fig. 1) .
Re-NLS contains a short nuclear localization signal (NLS) peptide 39 in order to bring the Re complex to the nucleus in close proximity of DNA. Most approved PS localize in other organelles rather than the nucleus (e.g. membranes, mitochondria, lysosomes, endoplasmic reticulum and Golgi apparatus). 40 However, many PS have long been known to damage DNA upon light irradiation. 41, 42 The second conjugate, Re-Bombesin, holds a derivative of the neuropeptide bombesin, known for its excellent in vivo stability and biodistribution. 43, 44 The purpose of this peptide is to selectively transport the complex to cancer cells (over healthy cells), as it targets a receptor overexpressed in certain types of cancer. Both Re-NLS and Re-Bombesin were purified by preparative reverse phase HPLC and lyophilized to obtain light-yellow powders. The presence of the two expected bioconjugates was ascertained by HR ESI-MS and MALDI-TOF (Fig. S8 , S10, S12, S13 † Fig. S9 and S14 †) and elemental analysis.
Singlet oxygen production
In order to assess the phototoxic potential of our Re(I) organometallic complexes, Re-NH 2 and Re-COOH were assayed in water and acetonitrile for 1 O 2 production using both an indirect method -an N,N-dimethyl-4-nitrosoaniline (RNO)/histidine test 45 -and a direct detection by near-infrared luminescence. 46 In the first assay, histidine quenches 1 O 2 and the resulting trans-annular peroxide bleaches RNO absorbance at 440 nm ( Fig. S15 and S16 †). In acetonitrile, imidazole instead of histidine was used due to the poor solubility of histidine in this solvent. To verify the indirect method results, direct measurements of characteristic 1 O 2 near-IR luminescence at 1270 nm were performed (Fig. S17 †) . For both methods, 1 O 2 quantum yields were then calculated using phenalenone as the reference. [47] [48] [49] As can be seen in 
Intracellular localization
To understand the behaviour of the organometallic complexes Re-NH 2 and Re-COOH and of the bioconjugates Re-NLS and Re-Bombesin, their cellular localization was evaluated in HeLa cells. For this purpose, the cells were incubated with the compounds, fixed with formaldehyde and imaged by fluorescence microscopy. As shown in Fig. 2 , Re-NH 2 alone is observed exclusively in the cytoplasm and Re-COOH is homogeneously distributed throughout the cell. Conjugation to an NLS peptide greatly enhances Re complex accumulation in the nucleoli. These subnuclear domains mainly house ribosomal RNA transcription, processing and assembly, but they have other important functions, such as cell cycle and mitosis regulation, stress response and assembly of non-ribosomal ribonucleoprotein particles. 50 Multifunctional, nucleoli contain both DNA (mostly ribosomal) and RNA, as well as proteins, which are either dynamic or immobilized. Re-NLS could potentially interact with one or several of these components. While NLS sequences have been well characterized, nucleolar localisation signals (NoLS) have been far less defined. 51 They do seem to share structural motifs with NLS, such as the presence of Arg and Lys residues, and are even sometimes part of NLS.
52-54
Hence, it is also possible that the combination of NLS with the Re complex is recognized as a NoLS. Of note, a Ru complex conjugated to an octaarginine peptide with fluorescein has been found to be mainly localized in nucleoli. 55 On the other hand, some proteins are only captured by nucleoli as part of the cellular stress response that can be caused by toxins. 56 Thus, it cannot be excluded that the compound initially interacts with one of these proteins and is later transported with them to nucleoli. Overall, given the importance of nucleoli in proper cell function, the production of singlet oxygen by Re-NLS should severely affect cell health. Since it has been reported that the nucleoli localization could sometimes be observed as an artefact of cell fixation, 12 the results were confirmed in living cells (Fig. S22 †) . Re-Bombesin gave a very weak luminescence signal and therefore could not be localized. This could either be due to its poor uptake by cells or the quenching of the fluorescence inside the cell. Indeed, the luminescence of similar complexes has already been reported to be quenched by vitamin B 12 57 or in living cells. 22 
Cytotoxicity studies
With this information in hand, we then assessed the cytotoxicity of the Re complexes Re-NH 2 and Re-COOH and of bioconjugates Re-NLS and Re-Bombesin on two different cell lines, namely the cervical cancer (HeLa) and human fibroblast (MRC-5) cell lines. As shown in Table 2 , Re-NH 2 and Re-COOH alone only affected HeLa and MRC-5 cells at concentrations higher than 100 μM. Conjugation of the bombesin derivative to Re-COOH did not affect its toxicity to HeLa cells, but made Re-Bombesin moderately toxic to MRC-5 cells. The latter have already been reported to be slightly affected by bombesin derivatives, albeit less than the cancer cells. 58 The difference in Re-Bombesin cytotoxicity to HeLa and MRC-5 could also be due to the fact that the bombesin derivative used in this study has been optimized on the androgen-independent human prostate cancer (PC-3) cell line. 43, 44 PC-3 cells mainly overexpress gastrin-releasing peptide (GRP) receptor of the bombesin receptor family. 59 HeLa, on the other hand, mostly express bombesin receptor subtype 3 (BRS-3). Although BRS-3 can interact with the same ligands as GRP receptor, its affinity for them is lower. 59 In any case, the cytotoxicity of our Re-Bombesin to MRC-5 is lower compared to bombesin- (Fig. S19 †) . DNA incubated with our compounds in the dark did not show a significant effect up to the highest concentration used.
Conclusions
In this article, we present one of the first studies on the use of Re(I) organometallic complexes as photosensitizers for PDT purposes. We demonstrated that Re(I) tricarbonyl N,N-bis-(quinolinoyl) complexes could efficiently produce 1 O 2 in lipophilic environments and induce DNA damage. Importantly, the localization or cellular uptake of the organometallic complexes could be controlled by attachment to targeting molecules. Although the irradiation wavelengths used in this study are not ideal since they only slightly penetrate through the skin, this work opens new avenues for the search for metalcontaining photosensitizers. Indeed, of the 14 PDT agents accepted by the FDA, two already contain a metal ion (lutetium and tin) and another one containing a palladium ion (Tookad) is in clinical trial phase III. 40, 67 We believe that the specific physico-chemical properties of metal complexes and in particular of organometallic complexes will have an important role to play in this field of research. In addition, since 99m Tc analogues of Re(I) tricarbonyl N,N-bis(quinolinoyl) complexes can be easily prepared, in vivo imaging studies could be performed, shedding light on important biodistribution data.
Experimental section

Materials
Chemicals and solvents were of reagent grade or better and were purchased from commercial suppliers. They were used without further purification unless otherwise specified. The plasmid pcDNA3 was obtained from Invitrogen.
Instrumentation and methods
1 H and 13 C NMR spectra were recorded using Bruker 400 and 500 spectrometers. Elemental microanalyses were obtained on a LecoCHNS-932 elemental analyser. High-resolution accurate mass spectra were performed on a Bruker maXis QTOF highresolution mass spectrometer (Bruker Daltonics, Bremen, Germany). UV spectra were recorded using a Carry 50 Scan Varian spectrophotometer. ESI-MS and LC-MS spectra were obtained using a Bruker Daltonics HCT 6000 mass spectrometer. LC-MS spectra were measured using an Acquity™ from Waters system equipped with a PDA detector and an auto sampler using an Agilent Zorbax 300SB-C18 analytical column (3.5 μm particle size, 300 Å pore size, 150 × 4.6 mm). The LC run (flow rate: 0.5 mL min 
Synthesis and characterization
Re-NH 2 . The complex was synthesised by following a previously published procedure. The analytical data matched those previously reported. 21 Re-COOH. The complex was synthesised by following a previously published procedure. The analytical data matched those previously reported. 19 
Peptide synthesis
The peptide synthesis was performed similarly to a procedure reported by Metzler-Nolte. 37 More specifically, the peptides with C-terminal amide were prepared manually in one-way polypropylene syringes (5 or 10 mL) equipped with a frit using a standard solid-phase peptide synthesis procedure. All reactions were carried out using a mechanical shaker. Polystyrene resin beads of TentaGel S RAM Lys(Boc)Fmoc (capacity 0.23 mmol g −1 ) or TentaGel S RAM (capacity 0.24 mmol g −1 )
were swollen in DMF for 1 hour before use. The resin was deprotected with piperidine (20% v/v in DMF) for 2 + 10 min. The resin was then washed with DMF (5×), DCM (5×), and DMF (5×). A Fmoc-protected amino acid was first pre-activated (4.5 equiv. amino acid, 4 equiv. TBTU, 8 equiv. DIPEA in DMF) for 2 min and then reacted with the resin for 30 min. Afterwards, the resin beads were washed with DMF (5×) and DCM (5×), and a Kaiser test was performed to check if the coupling was complete. Prior to cleavage, the resin was shrunk in methanol and dried. The peptides were cleaved using a mixture of trifluoroacetic acid-water-triisopropylsilane, 38 : 1 : 1 v/v/v (3 × 1 mL, for 1.5 h each). The collected solutions were combined and dried and the crude peptides were precipitated with cold ether. They were then purified by preparative HPLC. Singlet oxygen production N,N-Dimethyl-4-nitrosoaniline/histidine assay. The singlet oxygen production was measured by the N,N-dimethyl-4-nitrosoaniline/histidine assay based on the oxidation of histidine by singlet oxygen and the subsequent reaction of the oxidised histidine with N,N-dimethyl-4-nitrosoaniline as previously described. 45, 68 The absorbance of the compound was adjusted to approximately 0.2 at the irradiation wavelength. In practice, 20 mM DMSO stock solution of compound to measure were diluted in 4 mL PBS solution ( pH 7.4) containing N,Ndimethyl-4-nitrosoaniline (25 μM) and histidine (0.01 M) and irradiated in fluorescence quartz cuvettes (width 1 cm). Bleaching of N,N-dimethyl-4-nitrosoaniline was followed by monitoring of the absorption at 440 nm. Negative control experiments were run by repeating the measurements in the absence of histidine. The same conditions were also used for singlet oxygen detection in acetonitrile, except that imidazole was used instead of histidine due to the low solubility of histidine in this solvent. In addition, the absorbance peak of N,Ndimethyl-4-nitrosoaniline shifts to 415 nm in acetonitrile. The absorbance at 440/415 nm was then plotted as a function of irradiation time and the quantum yields of singlet oxygen formation (Φ sample ) were calculated using phenalenone as the standard (Φ reference ) with the following formula:
where S is the slope of the absorbance vs. irradiation time and I is the rate of light absorption calculated as the overlap of the lamp emission spectra and the absorption spectra of the compound according to the following formula:
where I 0 is the light-flux intensity of the lamp and A is the absorbance of the compound. 
nm).
Singlet oxygen near-IR luminescence at 1271 nm was measured by recording spectra from 1200 to 1350 nm (emission slit 5 nm, detector sensitivity 100, integration 3 (1)). The intensity of irradiation was varied via neutral density filters. Singlet oxygen luminescence peaks at different irradiation intensities were integrated and the resulting areas were plotted vs. irradiation intensities. The quantum yields were then calculated by applying the same formulas as those for the N,Ndimethyl-4-nitrosoaniline/histidine assay.
DNA photo-cleavage
The DNA photo-cleavage effect provoked by complexes Fig. S19 †) . A series of negative controls of the plasmid treated with different concentrations of Re-NH 2 , Re-NLS, Re-COOH and Re-Bombesin in the dark was used for comparative purposes. The cleavage of the target plasmid not photo-mediated was also studied at different incubation temperatures and in the presence of the restriction enzyme BstXI (1 h incubation at 37°C) which linearized pcDNA3 (see Fig. S20 †) . Upon irradiation, loading buffer (2.5% Bromophenol Blue, 1% SDS, 0.1 M EDTA, 20% Ficoll 400 in 100 mL of H 2 O) was added to samples and they were analyzed by electrophoresis in 0.8% agarose in TBE 1× (diluted from a 10× solution of 108 g of Tris/HCl, and 55 g of H 3 BO 3 in 900 mL of H 2 O) at 70 V (BioRad Powerpack 1000, BioRad) for 2 h. The gel was prestained with 0.5 μg mL −1 ethidium bromide, photographed and worked out with an AlphaDigiDoc 1000 CCD camera (Buchner Biotec AG) and AlphaImager software.
Cell culture
Human cervical carcinoma cells (HeLa) were cultured in DMEM (Gibco) with 5% fetal calf serum (FCS, Gibco), 100 U mL penicillin, and 100 μg mL −1 streptomycin at 37°C and 5% CO 2 . Normal lung fibroblasts (MRC-5) were maintained in F-10 medium (Gibco) supplemented with 10% fetal calf serum (FCS, Gibco), 100 U mL −1 penicillin, and 100 μg mL −1 streptomycin at 37°C and 5% CO 2 .
Cytotoxicity studies
The cytotoxicity of the rhenium complexes and their bioconjugates non-UV-irradiated or UV-irradiated to HeLa cells was measured by a fluorometric cell viability assay using Resazurin (Promocell GmbH). Cells were seeded in triplicates in 96-well plates at a density of 4 × 10 3 cells per well in 100 μL 24 h prior to treatment. To assess the cytotoxicity, cells were treated with increasing concentrations of compounds for 48 h. For phototoxicity studies, cells were treated with increasing concentrations of the compounds for 4 h only. After that, the medium was removed and replaced by complete medium prior to 10 min UV-A irradiation (30 kJ m −2 ). Cells were then returned to the incubator for 48 h. After incubation, the medium was replaced by 100 μL complete medium containing resazurin (0.2 mg mL −1 final concentration). Upon 4 h of incubation at 37°C, the fluorescence of the highly red fluorescent resorufin product was quantified at 590 nm emission with 540 nm excitation wavelength using a SpectraMax M5 microplate reader.
In vitro fluorescence evaluation
Cellular localization of the luminescent rhenium complexes and bioconjugates was assessed by fluorescence microscopy. HeLa cells were grown on 18 mm Menzel-Glaser coverslips in 2 mL complete medium at a density of 1 × 10 5 cells per mL and incubated for 1 or 2 h with Rhenium complexes at their IC 50 or at 100 μM for nontoxic complexes. Cells were fixed in a 4% formaldehyde solution in PBS and mounted on slides for viewing by confocal microscopy using a CLSM Leica SP5 microscope. The rhenium complexes were excited at 405 nm and the emission above 420 nm was recorded. For living cell imaging, cells were grown on 35 mm Cellview glass bottom dishes (Greiner), washed and kept in 1× PBS prior to imaging using an Olympus IX 81 motorized inverted microscope (Olympus, Hamburg, Germany) equipped with a 60× oilimmersion lens and a digital camera. The Rhenium complex was visualized using the Cy3 filter set of the Olympus microscope (ex., 550 nm; em., 570 nm).
